Ads
    Related paper
  1. Cardiovascular Safety of Incretin-Based Drugs in Type Two Diabetes Mellitus Patients
  2. GLYCOSYLATED HEMOGLOBIN AS A RISK ASSESSMENT OF THE CARDIOVASCULAR LESIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
  3. Oxidizing modification of albumens in plasma of blood of patients by diabetes mellitus of type 2 iin dependence on degree of indemnification of carbohydrate exchange and duration of diabetes mellitus of type 2
  4. THE CYTOPROTECTIVE EFFECT OF INTERLEUKIN 4 ON FIBROBLASTS COCULTERED WITH THE MONONUCLEARS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND THOSE WITH TYPE 2 DIABETES MELLITUS AND CHRONIC FOOT ULCERS IN A 3D CULTURE MODEL
  5. Atherogenic Dyslipidemia: An Important Risk Factor for Cardiovascular Disease in Metabolic Syndrome and Type 2 Diabetes Mellitus Patients
  6. A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus
  7. Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease
  8. COMBINED THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS USING ATORVASTATIN AND FENOFIBRATE: EFFICACY AND SAFETY EVALUATION
  9. Effects of Pedometer Based Walking Program on Diabetes Treatment Satisfaction Scores in Patients with Type 2 Diabetes Mellitus
  10. DIABETIC NEPHROPATHY IN THE STRUCTURE OF MICROVASCULAR COMPLICATIONS OF DIABETES MELLITUS: THE COMPARATIVE EVALUATION OF COURSE FEATURES AT PATIENTS WITH TYPE I AND II DIABETES MELLITUS